Ocugen Inc (OCGN) 13F Holdings Overview (Q2 2026)

OCGN ranks #3689 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

OCGN is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

150 institutions disclose a position in OCGN, but none treat it as a major bet — even Ikarian Capital, LLC, its most concentrated holder, allocates just 0.7% of its own portfolio to it.

BlackRock has added to its OCGN position for two straight quarters, increasing it by $35.2M to reach $41.3M today.

Goldman Sachs Group Inc has trimmed its OCGN position for two straight quarters, cutting it by $1.5M while still holding $1.6M.

OCGN is down 0.8% today, but institutions show net buying of $57.6M this quarter — a divergence between today's price move and the underlying institutional flow.

OCGN reported a net loss of $81.8M over the trailing twelve months.

• Not yet profitable — net loss of $81.8M over the trailing twelve months
• Revenue declined 3.7% year over year
• Net income declined year over year, from -$56.9M to -$81.8M
• Operating cash flow was negative, using $57.0M in cash
• Current ratio of 1.06x — below the conventional 1.5x liquidity buffer
• Total liabilities currently exceed total assets (negative shareholder equity)